Sort
82,697 grants matching “vaccine development”
Development of Pre-Erythrocytic Malaria Vaccines
$3,223,147Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Sequencing Analysis and Resource Dissemination core
$3,222,411Donna Muzny · Baylor College Of Medicine · U19 · FY2024 · AI
Alabama-Clinical Trials Unit
$3,222,269Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2010 · AI
Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network
$3,221,499Benoit Masse · Fred Hutchinson Cancer Research Center · U01 · FY2006 · AI
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
$3,219,613Mark M Davis · Stanford University · U19 · FY2019 · AI
HIV, TB, and Malaria Vaccine Development for Africa
$3,219,459Duke University · P01 · FY2005 · AI
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA
$3,219,060Dana-Farber Cancer Institute · P01 · FY2003 · CA
SHIV/HIV Env-Antibody Coevolution as a Guide to Iterative Vaccine Design
$3,218,740George M Shaw · University Of Pennsylvania · P01 · FY2021 · AI
Durable Antibody Mediated Protection Against HIV
$3,215,425Robert C Gallo · University Of Maryland Baltimore · P01 · FY2016 · AI
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS
$3,213,894University Of New South Wales · N01 · FY2000 · AI
Systems Biological Analysis of Innate and Adaptive Responses to Vaccination
$3,213,142Bali Pulendran · Emory University · U19 · FY2010 · AI
Cellular Immunity to Category A-C Viruses in Humans
$3,211,928Univ Of Massachusetts Med Sch Worcester · U19 · FY2005 · AI
UTHSC Regional Biocontainment Laboratory: Upgrade of Facility and Building System
$3,211,742Colleen B Jonsson · University Of Tennessee Health Sci Ctr · G20 · FY2021 · AI
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$3,210,574Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2022 · DC
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)
$3,209,830Abhijit Prakash Limaye · University Of California, San Francisco · U01 · FY2025 · AI
Cellular Immunity to Category A-C Viruses in Humans
$3,209,684Robert William Finberg · Univ Of Massachusetts Med Sch Worcester · U19 · FY2011 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
$3,206,850Maria Virginia Pascual · Baylor Research Institute · U19 · FY2014 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$3,205,924Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Clinical Studies of Vaccines for Pandemic Influenza
$3,203,625Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network
$3,203,442Benoit Masse · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI
Mechanisms of naturally-acquired immunity to malaria
$3,202,656Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER
$3,202,049Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2020 · AI
Safeguard the household: comprehensive AIDS research
$3,200,000Wits Health Consortium (Pty), Ltd · U19 · FY2002 · AI
Synthetic DNA & Novel Env Vaccine for HIV
$3,200,000David B. Weiner · University Of Pennsylvania · U19 · FY2015 · AI
Optimizing the Immunogenicity of MVA-Based AIDS Vaccines
$3,199,984Mark B. Feinberg · Emory University · U19 · FY2007 · AI